Hepatic-specific activation of peroxisome proliferator-activated receptor γ coactivator-1β protects against steatohepatitis.
about
Energy metabolism in the liverRole of mitochondria in nonalcoholic fatty liver diseaseThe roles of microRNA families in hepatic fibrosis.OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease.MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression.Sophocarpine attenuates liver fibrosis by inhibiting the TLR4 signaling pathway in rats.Genetic models of PGC-1 and glucose metabolism and homeostasisc9,t11-Conjugated linoleic acid ameliorates steatosis by modulating mitochondrial uncoupling and Nrf2 pathway.Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β.Increased Hepatic Fatty Acids Uptake and Oxidation by LRPPRC-Driven Oxidative Phosphorylation Reduces Blood Lipid Levels.Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease.Murine models provide insight to the development of non-alcoholic fatty liver disease.Triglyceride Metabolism in the Liver.PGC-1β suppresses saturated fatty acid-induced macrophage inflammation by inhibiting TAK1 activation.
P2860
Q26996783-40536A9D-A40D-4FC8-8C5D-DF080132321DQ27028142-AB70B885-7249-4158-B21C-8F544D57B789Q33868794-1D74A70F-77D0-4913-A20F-34EFF77CEE7EQ35620205-F567E38E-9F95-45CB-89E6-5507778792E0Q36719130-A68C606B-53AC-402F-9500-0720999528EAQ37596197-64B622FC-B1D3-4261-8F2D-ADDD0BAE835BQ37619755-4F7E6F0C-236B-454B-9922-C1E0BA099F8BQ37716350-16C1CC05-B472-495D-A077-9EC1AF0DBFE5Q38927251-A3A5A1D2-6171-429F-96C6-3D235DC14A3DQ39555861-500E580B-E433-4C14-B648-97BD95C43565Q42014196-529A517F-4A06-4482-802B-17DDD5EA0100Q42134707-E7EBE94C-AEA1-4BFD-8CD4-6177E3EA7D02Q47719467-54CE18C1-CAF0-481F-928D-C20C678848D9Q53802165-15F71C60-CD20-4A3C-BD2C-FB582A1D50C2
P2860
Hepatic-specific activation of peroxisome proliferator-activated receptor γ coactivator-1β protects against steatohepatitis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Hepatic-specific activation of ...... tects against steatohepatitis.
@en
Hepatic-specific activation of ...... tects against steatohepatitis.
@nl
type
label
Hepatic-specific activation of ...... tects against steatohepatitis.
@en
Hepatic-specific activation of ...... tects against steatohepatitis.
@nl
prefLabel
Hepatic-specific activation of ...... tects against steatohepatitis.
@en
Hepatic-specific activation of ...... tects against steatohepatitis.
@nl
P2093
P2860
P356
P1433
P1476
Hepatic-specific activation of ...... tects against steatohepatitis.
@en
P2093
Antonio Moschetta
Dominga Latorre
Elena Bellafante
Gaetano Villani
Lorena Salvatore
Stefania Murzilli
P2860
P304
P356
10.1002/HEP.26222
P407
P577
2013-03-14T00:00:00Z